Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

IDEXX Laboratories, Inc. IDXX

Healthcare  —  Diagnostics & Research
519.26 5.87 1.14% as of 25 Sep
Market cap
$40.2B
P/E
36.2×
S&P 500 Member Cash Flow Champion (3y)
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending)
Download Excel — free account

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments 391.85 471.93 123.79 90.33 383.93 144.45 112.55 453.93 288.27 180.07
Receivables 204.49 234.60 248.86 269.31 331.43 368.35 400.62 457.45 473.58 552.38
Inventory 158.03 164.32 173.30 195.02 209.87 269.03 367.82 380.28 381.88 377.76
Other current assets 91.21 101.14 108.22 124.98 137.51 173.82 220.49 203.60 256.18 303.62
Total current assets 845.58 971.99 654.17 679.64 1,062.74 955.66 1,101.48 1,495.25 1,399.90 1,413.83
Property, Plant, Equpment (Net) 357.42 379.10 437.27 533.85 555.17 587.67 649.47 702.18 713.12 747.38
Goodwill and Intangible Assets (Total) 224.38 243.72 256.31 298.19 295.89 458.38 459.47 450.46 516.78 523.85
Long-term assets (Other) 103.32 118.62 189.59 240.19 289.60 330.40 417.73 496.53 547.52 542.48
Total non-current assets 685.12 741.43 883.18 1,152.84 1,231.82 1,481.55 1,645.29 1,764.67 1,893.55 1,936.93
Total Assets 1,530.70 1,713.42 1,537.35 1,832.48 2,294.56 2,437.20 2,746.77 3,259.93 3,293.44 3,350.76
Notes Payable 611.00 655.00 398.94 288.77 — 73.50 579.00 250.00 250.00 398.00
Accounts Payable 60.06 66.97 69.53 72.17 74.56 116.14 110.22 110.64 114.21 110.41
Accrued Expenses 236.13 253.42 260.68 322.94 415.65 458.91 433.66 478.71 502.12 530.15
Current Part of Debt 611.00 655.00 399.00 304.00 49.99 75.00 74.98 75.00 167.79 75.00
Current Revenue (Deferred) 27.38 29.18 41.29 41.46 42.57 40.03 37.94 37.20 33.80 35.26
Total current liabilities 934.57 1,004.57 770.44 725.34 582.76 763.58 1,235.80 951.55 1,067.92 1,148.81
Long Term Debt (Total) 593.11 606.08 601.35 698.91 858.49 775.21 694.39 622.88 449.79 374.84
Non-current Revenue (Deferred) 33.02 35.55 60.70 48.74 46.16 41.17 30.86 28.53 26.94 32.18
Long Term Tax Liability (Deferred) 39.29 25.35 29.27 33.02 11.71 8.94 8.15 7.24 11.31 31.87
Non-current Liabilities (Other) 38.94 95.72 84.83 81.16 85.60 70.94 67.59 65.53 44.34 56.53
Total non-current liabilities 704.35 762.69 776.14 929.31 1,079.01 983.63 902.23 823.85 630.21 596.56
Total liabilities 1,638.92 1,767.26 1,546.58 1,654.65 1,661.77 1,747.21 2,138.03 1,775.40 1,698.13 1,745.38
Additional Paid In Capital 1,011.90 1,073.93 1,138.22 1,213.52 1,294.85 1,377.32 1,463.22 1,569.57 1,673.86 1,826.75
Common Stock (Net) 10.33 10.43 10.51 10.57 10.65 10.69 10.72 10.75 10.78 10.84
Retained Earnings 540.40 803.55 1,167.93 1,595.65 2,175.60 2,920.44 3,599.53 4,444.57 5,332.44 6,391.90
Treasury Stock 1,633.44 1,911.53 2,288.90 2,600.54 2,799.89 3,570.69 4,392.11 4,474.68 5,334.01 6,561.36
Common Equity (Total) (108.21) (53.84) (9.23) 177.82 632.79 689.99 608.74 1,484.53 1,595.31 1,605.38
Shareholders Equity (Total) (108.21) (53.84) (9.23) 177.83 632.80 689.99 608.74 1,484.53 1,595.31 1,605.38
Shareholders Equity and Liabilities (Total) 1,530.70 1,713.42 1,537.35 1,832.48 2,294.56 2,437.20 2,746.77 3,259.93 3,293.44 3,350.76
Shares (Common) 87.97 87.10 86.10 85.47 85.45 84.56 82.89 83.03 81.60 79.71
Shareholders Equity (Tangible) (332.60) (297.56) (265.55) (120.37) 336.91 231.61 149.27 1,034.07 1,078.54 1,081.54
Net Debt 812.26 789.15 876.55 912.58 524.55 705.75 656.82 243.95 329.31 269.77
Total Debt 1,204.11 1,261.08 1,000.35 1,002.91 908.48 850.20 769.37 697.88 617.57 449.84

Fold the line items

In millions of $ except per-share values · columns are period end dates